1-3 of 3
Addolorata Maria Luce Coluccia
Close
Sort by
Journal Articles

Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34 + chronic myeloid leukemia progenitors, preserving normal stem cells

Giovanni Reddiconto, Claudia Toto, Ilaria Palamà, Simone De Leo, Emanuela de Luca, Serena De Matteis, Luciana Dini, Carlo Gambacorti Passerini, Nicola Di Renzo, Michele Maffia, Addolorata Maria Luce Coluccia
Journal: Blood
Blood (2012) 119 (10): 2335–2345.
https://doi.org/10.1182/blood-2011-06-361261
Published: 2012
Journal Articles

Validation of PDGFRβ and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib

Addolorata Maria Luce Coluccia, Teresa Cirulli, Paola Neri, Domenica Mangieri, Maria Cristina Colanardi, Antonio Gnoni, Nicola Di Renzo, Franco Dammacco, Pierfrancesco Tassone, Domenico Ribatti, Carlo Gambacorti-Passerini, Angelo Vacca
Journal: Blood
Blood (2008) 112 (4): 1346–1356.
https://doi.org/10.1182/blood-2007-10-116590
Published: 2008
Journal Articles

Bcl-X L down-regulation suppresses the tumorigenic potential of NPM/ALK in vitro and in vivo

Addolorata Maria Luce Coluccia, Silvia Perego, Loredana Cleris, Rosalind Helen Gunby, Lorena Passoni, Edoardo Marchesi, Franca Formelli, Carlo Gambacorti-Passerini
Journal: Blood
Blood (2004) 103 (7): 2787–2794.
https://doi.org/10.1182/blood-2003-09-3144
Published: 2004